Sanofi (SNY) Cash from Investing Activities (2009 - 2026)

Sanofi (SNY) has 8 years of Cash from Investing Activities data on file, last reported at -$2.7 billion in Q1 2026.

• Quarterly Cash from Investing Activities fell 226.73% year-over-year to -$2.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 billion (up 152.93% YoY) and the FY2025 annual result came in at -$2.8 billion, up 39.52% from the prior year.
• Cash from Investing Activities grew to -$2.7 billion in Q1 2026 per SNY's latest filing, from -$2.8 billion in the prior quarter.
• The five-year high for Cash from Investing Activities was $10.8 billion in Q2 2025, with the low at -$4.7 billion in Q4 2024.
• Average Cash from Investing Activities over 3 years is -$541.5 million, with a median of -$1.7 billion recorded in 2025.
• Year-over-year, Cash from Investing Activities surged 428.48% in 2025 and tumbled 226.73% in 2026.
• Sanofi's Cash from Investing Activities stood at -$4.7 billion in 2024, then surged by 39.52% to -$2.8 billion in 2025, then advanced by 6.37% to -$2.7 billion in 2026.
• Business Quant data shows SNY's Cash from Investing Activities at -$2.7 billion in Q1 2026, -$2.8 billion in Q4 2025, and -$369.4 million in Q3 2025.